Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05492396 · ClinicalTrials.gov registry record

Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant

A clinical trial of Hip Injuries and Tendon Injuries, sponsored by Ohio State University.

Active
Registry status
30
Enrollment target
3
Study locations

NCT05492396: Active study of Hip Injuries and Tendon Injuries, sponsored by Ohio State University.

NCT05492396 is a study of Hip Injuries and Tendon Injuries that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 30 participants, below the 2,117-participant average among 7 other Hip Injuries trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05492396, a study of Hip Injuries and Tendon Injuries, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
30 participants
Enrollment target
3
Study locations

Study Summary

This is a prospective, single-center study design with enrollment of 15 subjects. The 15 subjects will all undergo standard gluteus medius repair that includes augmentation with the biointegrative implant. This is a small observational study. As such, we expect that the results from 15 subjects will give an adequate understanding of post surgical healing.

Primary Outcome

Graded as 'Intact/Attenuated/Disrupted'. Intact being the positive outcome, disrupted being the negative outcome.

Interventions

  • DEVICE Standard gluteus medius repair with Tapestry Biointegrative implant

Study Locations (3)

Ohio

  • Jameson Crane Sports Medicine Institute - Columbus
  • The Ohio State University Hospital East - Columbus
  • Ohio State Outpatient Care New Albany - Westerville

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-08-01
Est. Completion 2026-01
Ohio State University

552 total trials

What the registry record for NCT05492396 still lists

NCT05492396 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,117-participant average among 7 other Hip Injuries trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Hip Injuries appearing as the primary indexed condition, and to 1 intervention - of which Standard gluteus medius repair with Tapestry Biointegrative implant is the first listed.

NCT05492396 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT05492396 about?

NCT05492396 is a clinical study titled "Evaluation of Healing Following Open Gluteus Medius Repair With Biointegrative Implant". This is a prospective, single-center study design with enrollment of 15 subjects. The 15 subjects will all undergo standard gluteus medius repair that includes augmentation with the biointegrative implant. This is a small observational study. As such, we expect that the results from 15 subjects will...

What is the current status of trial NCT05492396?

This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2022-08-01. Estimated completion is 2026-01.

What conditions does trial NCT05492396 study?

This clinical trial studies the following conditions: Hip Injuries, Tendon Injuries, Orthopedic Procedures.

What interventions are being tested in trial NCT05492396?

The interventions under investigation include: Standard gluteus medius repair with Tapestry Biointegrative implant (DEVICE).

Who is sponsoring clinical trial NCT05492396?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05492396 being conducted?

This trial has 3 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hip Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05492396, the US trial registry maintained by the National Library of Medicine. NCT05492396 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.